MiniMed Group, Inc. (MMED)
Nasdaq: MMED · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2025
Income statement, as filed
In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Period ending | Apr 24, 2026 | Apr 25, 2025 | Apr 26, 2024 |
| Report filed | Jun 29, 2026 | · | · |
| Revenue | 3,102 | 2,715 | 2,469 |
| Cost of revenue | 1,422 | 1,187 | 1,032 |
| Gross profit | 1,680 | 1,528 | 1,436 |
| Research and development | 448 | 436 | 437 |
| Selling, general and administrative | 1,183 | 1,080 | 1,057 |
| Operating income | -190 | -146 | -69 |
| Other income (expense), net | 1 | -1 | -1 |
| Income before income taxes | -189 | -147 | -70 |
| Income tax expense | 128 | 52 | 38 |
| Net income including non-controlling interests | -317 | -198 | -107 |
| Net income to non-controlling interests | 16 | 15 | 5 |
| Net income | -333 | -213 | -112 |
| Earnings per share, basic | -1.30 | -0.84 | -0.44 |
| Earnings per share, diluted | -1.30 | -0.84 | -0.44 |
| Weighted average shares, basic | 256,600,000 | 252,800,000 | 252,800,000 |
| Weighted average shares, diluted | 256,600,000 | 252,800,000 | 252,800,000 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding